Large lab firm, behind $25M project, looks to get larger

A stalwart Fort Myers company — with a nod to enthusiastic investors — targets major advances.


  • By
  • | 6:00 a.m. August 23, 2019
  • | 0 Free Articles Remaining!
Stefania Pifferi. Fort Myers-based NeoGenomics CEO Doug VanOort says the company is about to go on a hiring surge.
Stefania Pifferi. Fort Myers-based NeoGenomics CEO Doug VanOort says the company is about to go on a hiring surge.
  • Health Care
  • Share

One of the region’s largest medical services companies plans to spend tens of millions of dollars on a new headquarters in Fort Myers.

NeoGenomics (NASDAQ: NEO) provides cancer-focused genetic testing services to doctors and patients worldwide, leveraging a network of laboratories with locations as far as Fresno, Calif., and Rolle, Switzerland. Founded in 2002, NeoGenomics, a Business Observer company to watch in 2016, generated $2.6 million in net income in 2018 on $276.7 million in revenue.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content